LATEST MEDICAL CANNABIS STOCK NEWS
Citizen Stash Cannabis Reaffirms its Support of the Plan of Arrangement with The Valens Company Inc.
Citizen Stash Shareholders are encouraged to submit their proxies for the Special Meeting of Shareholders and Option holders on Monday, November 1, 2021
Citizen Stash Cannabis Corp. "Citizen Stash") (formerly Experion Holdings Ltd.) (TSXV:CSC) (OTCQB:EXPFF) (FRANKFURT:MB31) today confirmed its continued support of the proposed plan of arrangement (the "Valens Transaction") with The Valens Company Inc. ("Valens"). Following... Read more
Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) ("Matica" or the "Company") is pleased to announce that the Company's subsidiary, RoyalMax Biotechnology Canada Inc. D.B.A. West Island Culture ("West Island") has signed a Master Supply Agreement with the Ontario Cannabis Retail Corporation, doing business as the Ontario Cannabis Store (the "OCS"), which is the sole wholesale distributor of cannabis for the... Read more
Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that it has reached an agreement (the "Agreement") with 36Eight Technologies Inc. ("36Eight"), a growing bioinformatics pharmacological healthcare data and technology company, which has developed... Read more
Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, today announces that, as a result of a continuous disclosure review conducted by staff of the Ontario Securities Commission (“OSC”), the staff of the Corporate Finance Branch requested that the Company refile its... Read more
Transaction Strengthens Canopy Growth's U.S. Ecosystem and Increases U.S. Cannabis Market Exposure Upon Federal Permissibility
Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED) (NASDAQ: CGC) and Mountain High Products, LLC, Wana Wellness, LLC and The Cima Group, LLC (collectively, "Wana" and each, a "Wana Entity") are pleased to announce that they have entered into definitive agreements (the... Read more
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development today provided an update on the progress and significant achievements of its lead investigational drug, QIXLEEF™.
QIXLEEF™ is a botanical inhaled drug product with a fixed ratio of THC and CBD that meets USA cGMP regulatory requirements. The drug will be first... Read more
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), today announced that it has closed its previously announced private placement of the Company's common shares (a "Common Share" and, collectively, the "Common Shares") and warrants to purchase common shares ("Common Warrants") to institutional investors for aggregate gross proceeds to the Company of C$8,227,150 million (the "Private... Read more
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., is celebrating today’s expanded launch of Classix, a heritage California product brand, in five additional markets – Arizona, Delaware, Illinois, Massachusetts and New Jersey.
“Classix is a... Read more
WEED, Inc. (OTCQB:BUDZ) ("WEED" or the "Company"), a cannabis and hemp bioresearch company based in the USA, announced today that WEED's CEO, Glenn E. Martin has completed the formation of HEMP BioSciences Inc., as an Arizona corporation wholly owned by its parent WEED, Inc.
"Thanks to the Company's extensive R&D history in cannabis and hemp markets globally, we believe WEED is on the verge of another explosive... Read more
Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) ("Next Green Wave", "NGW" or the "Company"), a premium seed-to-shelf craft cannabis producer, is pleased to announce the following financial update:
High Level Q3 2021 Results
The Company has exceeded its Q3 2021 Adjusted EBITDA* projection (originally announced HERE).
In the below table, the Company has provided Revenue and Adjusted EBITDA* for the last four... Read more
Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, has formed a new exclusive sponsored research agreement with Emerald Health Biotechnology Espana SLU (“EHBE”), focused on developing and characterizing novel molecules that can affect the... Read more
Citizen Stash Cannabis Corp. (the "Company" or "Citizen Stash") (TSXV:CSC) (OTCQB:EXPFF) (FRANKFURT:MB31) is pleased to announce the launch of its premium flower products into Nova Scotia where it will be available in cannabis retail stores within the province in the coming weeks.
The Company's wholly owned subsidiary, Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of premium cannabis, has... Read more
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced a New Acre Project sponsorship to support ALUS. The commitment is intended to fund environmental programs in the communities where Aurora facilities are located.
The sponsorship creates shared value for Aurora's customers, consumers, and patients by taking action to address climate change,... Read more
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Japanese division of the Company’s subsidiary Kannaway® experienced its largest revenue month in the division’s history for the month of September 2021.... Read more
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), today announced that it has entered into securities purchase agreements for a private placement of the Company's common shares (a "Common Share" and, collectively, the "Common Shares") and warrants to purchase common shares ("Common Warrants") to institutional investors for aggregate gross proceeds to the Company of approximately... Read more
Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced the presentation of a poster at the 2021 American Academy of Pediatrics (AAP) National Conference & Exhibition, which will be held virtually from October 8-11, 2021. A copy of the poster titled, “Longer Term Tolerability and... Read more
CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, applauds the California Legislature of its passage of AB 45, which yesterday was signed into law by Governor Gavin Newson. This new law will explicitly permit the retail sale of products containing hemp-derived extracts and... Read more
Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary cannabinoid-derived molecules to treat diseases with significant unmet need, has strengthened its management team with the appointment of Rhea Williams, MPH, as Head of Regulatory Affairs & Quality Assurance and Varun Khurana, PhD, as Senior Director of Research & Development.
Rhea Williams, MPH, brings over 25 years... Read more
Item 9 Labs Corp. (OTCQX: INLB) (the "Company")—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—today announced it has signed an Asset Purchase Agreement ("APA") for an existing dispensary license and storefront in Adams County, CO.
This will be the first corporate-owned shop under its cannabis dispensary franchise brand, Unity Rd., and is... Read more
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S. announced today the first Cannabist dispensary in Missouri, located in Hermann, is now open. This marks the ninth Cannabist location and the 75th active Columbia Care dispensary in the U.S. Cannabist... Read more
Khiron Life Sciences Corp. (TSXV: KHRN.V) (OTCQX: KHRNF) (FSE: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, will be participating in the Benzinga Cannabis Capital Conference, which will take place on October 14 and October 15 at the Marriott Marquis hotel in New York City.
Virtual access to the conference for those unable to attend in person is also available.
Alvaro... Read more
Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today reported financial results for the first fiscal quarter ended August 31, 2021. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated, and presented in accordance with accounting principles generally accepted in the U.S.... Read more
12-month observational study results presented at the International Pain Conference in Colombia on September 25th, 2021
1st research study of its kind with a significant patient base for medical cannabis in LatAm
1,453 patients in 12-month period, serviced at Khiron's Zerenia clinics in Colombia, using Khiron's CBD and THC oral sublingual medical cannabis oils
80% patients with positive clinic response for chronic pain,... Read more
VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), today announced a partnership with Delta 9 Cannabis Inc ("Delta 9") to offer Delta 9 products on VIVO's Canna Farms e-commerce... Read more
Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) ("Next Green Wave", "NGW" or the "Company"), a premium seed-to-shelf craft cannabis producer, is pleased to announce the following financial updates:
Loan Fully Repaid
As of September 30, 2021, the Company has used its cash-on-hand to fully repay the last of its outstanding debt, and as a result, the Company's only remaining liabilities on its Balance Sheet are trade... Read more
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® will partner with the non-profit organization The Por Grace Foundation. The partnership will be focused on raising awareness of the... Read more
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is very pleased to announce the appointment of Dr. Caroline MacCallum as a senior advisor and consultant for the Company.
Dr. MacCallum will be working with our team on the development and commercialization of the Company's Cannabinoid Sol-gel products. Her specialization in internal medicine and expertise in complex pain... Read more
Tetra is gearing up to launch REDUVO™, its first cannabinoid-derived medicine, in Canada.
REDUVO™ 5-year cumulative gross sales expected to reach $121M.
The Company has started numerous pre-launch activities to prepare for the introduction of REDUVO™ on the Canadian Market.
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery... Read more
Fiore Cannabis (CSE: FIOR) (OTCQX: FIORF) ("Fiore" or the "Company"), a licensed multi-state cannabis cultivator, producer and retailer, today provided a number of corporate updates including developments regarding its Apex cannabis cultivation and production facility near Las Vegas, Nevada.
The Company's partner, which has an option to purchase a cannabis cultivation licence for the Apex site from Fiore upon U.S. federal... Read more
Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) hosted a second annual adult-use retailer harvest party at its outdoor cultivation facility, with over 300 cannabis store owners, managers, budtenders and industry leaders attending. The two-day conference included retailer tours at the 86 acre outdoor site in Port Perry, Ont. and education sessions featuring the company’s cultivation... Read more
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce that a new patent application has been filed for Innocan's CBD Delivery System Technology, alongside the existing LTP (CBD Loaded Liposomes) and CLX (CBD Loaded Exosomes). The new patent application discloses a unique and novel delivery system allowing the controlled release of CBD into the blood stream with... Read more
Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is scheduled to participate in the following virtual investor conferences in October 2021:
A.G.P.' S VIRTUAL FALL CONSUMER CANNABIS CONFERENCEAttending 1x1 Meetings: Tuesday, October 5th 2021 Moderator: Aaron Grey, Managing... Read more
Item 9 Labs Corp. (OTCQX: INLB) (the "Company"), a vertically integrated, cannabis dispensary franchisor and operator that produces premium, award-winning products, today announced that the Company has added a senior-level marketing executive and a mid-level marketing professional to its marketing team. Their focus is on managing and advancing the accelerated sales and brand momentum that the business is... Read more
Today, Karma Water announced the launch of Karma CBD Water. This is the first CBD beverage to launch under the Karma wellness and probiotic waters beverage portfolio and has been developed in partnership with Canopy Growth Corporation, a world-leading diversified cannabis and hemp company. Karma CBD Water is crafted with Canopy Growth's Broad Spectrum CBD distillate made from US Hemp Biomass and powered by Karma's patented... Read more
Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated international cannabis leader with core operations in Latin America and Europe, is pleased to provide a corporate update on global medical cannabis operations:
Medical Cannabis
Latin America
Medical cannabis prescriptions grew by more than 40%, from Q2 2021
Year to date medical cannabis... Read more
Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) ("Next Green Wave", "NGW" or the "Company") the Company is pleased to confirm the appointment of Curtis Floyd to NGW's Board of Directors.
Mr. Floyd joins the Next Green Wave Board of Directors with an outstanding track record in business, entrepreneurship and leadership.
Currently, Mr. Floyd is:
a practicing attorney with The Law Offices of Curtis Floyd, holding... Read more
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), announced today it has received approval from the Cannabis Control Commission (CCC) and the Boston Cannabis Board (BCB) to commence operations as Cannabist at 21 Milk Street in downtown Boston, its co-located adult-use and medical dispensary previously known as Patriot Care. Cannabist Boston is one of three... Read more
Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, today announced the closing of its previously announced registered direct offering for the purchase and sale of 77,777,779 shares of its common stock (or common stock equivalents in lieu... Read more
Bidiol is the only full-spectrum cannabis oil that is fully produced domestically
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, has launched Bidiol, the first medical cannabis oil in Uruguay that is wholly produced domestically. The CBD oil is available in 3% and 10% concentrations and comes in 10mL and 30mL bottles, available in pharmacies... Read more
Unity Rd., the cannabis dispensary franchise from Item 9 Labs Corp. (OTCQX: INLB), continues to lead at the forefront of the industry. As part of the brand's commitment to cannabis education and franchise expansion, Unity Rd. will be presenting at the virtual MLive Cannabis Insights event on Thursday, October 7, which kicks off at 4:00 p.m. EDT. The presentation will include a live Q&A with Unity Rd.'s VP of... Read more
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), announced today it is partnering with three organizations – BIPOCANN, Virginia Minority Cannabis Coalition (VMCC) and Nolef Turns – to offer social equity-driven resources for the developing cannabis community in Virginia.
This group of partners is dedicated to ensuring that Virginia’s BIPOC community has... Read more
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., has received approval from the New York State Department of Health to commence cultivation and processing operations at its new facility in eastern Long Island, New York. The first harvest is planned... Read more
Item 9 Labs Corp. (OTCQX: INLB) (the "Company")—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—today announced it will participate in the A.G.P. Virtual Fall Consumer Cannabis Conference on Tuesday, October 5, 2021.
The conference features up to 30 select companies in the cannabis industry and will be attended by approximately 200... Read more
#1 Canadian LP in Global Medical Cannabis; Total Medical Cannabis Net Revenue Rose 9% Compared to Prior Year; Strong Adjusted Gross Margin before FVA of 68%
Business Transformation Plan on Track; Reiterates Annual Cost Savings of $60 Million to $80 Million, Providing Clear Pathway to Adjusted EBITDA Profitability
Balance Sheet Remains Strong with $440.9 Million of Cash at June 30, 2021; Working Capital Improves by $404.3... Read more
Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, today announced that it has entered into securities purchase agreements with several institutional investors, for the purchase and sale in a registered direct offering of 77,777,779 shares... Read more
Harvest One Cannabis Inc. (TSXV: HVT) (OTCQB: HRVOF) ("Harvest One" or the "Company"), a uniquely positioned cannabis-infused and non-infused consumer packaged goods ("CPG") leader, announces that further to the press release of the Company dated July 26, 2021, relating to the strategic advisory and consulting services to the Company (the "Consulting Services") to be provided by an arm's length service provider, Jonathan... Read more
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), hereby announces the filing by Ramot of a new patent application for a unique Cannabinoids exosome delivery platform - CLX, developed by Ramot and their researchers from Tel Aviv University. InnoCan holds worldwide exclusive option agreement to develop and commercialese the CLX and noticed Ramot on the intention to execute the... Read more
Unity Rd., the cannabis dispensary franchise from Item 9 Labs Corp. (OTCQX: INLB), announced today the signing of its newest agreements for New Jersey and Virginia alongside continued expansion across the Northeast region. The brand's growth strategy is twofold, including both helping interested entrepreneurs enter the complex industry while also partnering with existing dispensary owners via its Local Alliance Program. The... Read more
THC BioMed Intl Ltd. ("THC BioMed" or the "Company") is pleased to announced that 3 new THC BioMed products are to be listed and sold through the Ontario Cannabis Stores: Dragon's Lettuce dried cannabis, THC Kiss Cannabis Biscuits (Cocoa) and THC Kiss Cannabis Biscuits (Cinnamon.)
Dragon's Lettuce
We are pleased to introduce Dragon's Lettuce into Ontario. It's our most potent sativa landrace strain. It is cultivated... Read more
Item 9 Labs Corp. (OTCQX: INLB) (the "Company")—a vertically integrated, cannabis dispensary franchisor and operator that produces premium, award-winning products—today announced continued development of its cannabis dispensary franchise brand, Unity Rd., across the Northeastern United States. The industry trailblazer signed agreements for New Jersey and Virginia alongside continued expansion across the Northeast... Read more
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a global leader in the research and development of clinically validated cannabinoid medicines, is pleased to announce the US launch of the Zelira Dermatology Business' first product line, RAF FIVE™, through its dermatology subsidiary Ilera Derm LLC ("Zelira Dermatology").
The five-product RAF FIVE™ line consists of the Wash Away Gel Cleanser Acne Treatment,... Read more
THC BioMed Intl Ltd. ("THC BioMed" or the "Company") is pleased to announced that it has received orders from 30 dispensaries in the province Manitoba. The Company is also pleased to announce that it has begun shipping THC KISS cannabis edibles and dried cannabis to those dispensaries.
The website thckiss.buzz will be updated to add the Manitoba dispensaries to the list of dispensaries carrying THC BioMed... Read more
Puration, Inc. (OTC Pink: PURA) (“PURA”) has launched a hemp industry-wide strategic initiative to collectively market for multiple hemp growers and processors under a single brand name - Farmersville Hemp.
PURA has already forged partnerships with Alkame Holdings, Inc. (OTC Pink: ALKM), North American Cannabis Holdings, Inc. (OTC Pink: USMJ) and PAO Group, Inc. (OTC Pink: PAOG).
Early in Q4, PURA intends to... Read more
Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary cannabinoid-derived molecules to treat diseases with significant unmet need, announced today its research partner, the University of Mississippi will present late-breaking preclinical data evaluating different nanoemulsion formulations of its prodrug of tetrahydrocannabinol (THC), THCVHS, in addition to the superiority of... Read more
Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) (the "Company" or "BaM"), a multi-state operator focused on limited license markets, is pleased to report plans to enter the Michigan market with fully funded dispensary, cultivation and production facilities. BaM, through wholly owned subsidiaries, has leveraged its expertise of navigating licensing and approval processes gained with other state and local authorities, adding... Read more
Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Armando Anido, Chairman and Chief Executive Officer of Zynerba, will participate in a fireside chat during the 2021 Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021 at 11:20 a.m. ET.
Investors... Read more